Park Dental Partners, Inc.
PARKPark Dental Partners, Inc. in brief
Park Dental Partners, Inc. is a listed company in the Healthcare sector, based in Roseville, Minnesota, USA. Its market value was $105 M on 15 October 2026, which makes it the 18,543rd largest listed company in the world and the 3,494th largest in the USA on this site. Peter G. Swenson is its chief executive. Its shares trade under the symbol PARK (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Park Dental Partners, Inc.
As a dental resource organization, Park Dental Partners, Inc. provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices in Minnesota, Wisconsin and Arizona. Our network of affiliated dental practices employs 214 dentists, and consists of 990 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their dental practices across 86 practice locations. Our network of affiliated dental practices has been operating for over fifty years, beginning with the establishment of the general dentistry group in 1972. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today.
From the company's annual report filed with the US SEC: read the report
Park Dental Partners, Inc. timeline
- 2025
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 🔔Initial public offering on NasdaqFinal prospectus filed with the SEC on 3 December 2025; shares registered for exchange trading on 2 December 2025.
Events of Park Dental Partners, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,390 (Aug 2026) · #3,431 (Sep 2026) · #3,497 (Oct 2026)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- 4.8×
- Free cash flow yield
- —
- Net margin
- —
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- 87.8%
- Net debt
- $-13M
Quarterly results
Latest quarter to Sep 2026: revenue $65M (+6.0% on a year earlier), net income $2M.
SEC filings
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Nov 12, 20268-KCurrent reportResults of operations
- Nov 9, 20268-KCurrent reportMaterial agreement · Acquisition or disposal completed · New financial obligation · Unregistered share sale · Regulation FD disclosure
- Oct 13, 20268-KCurrent report
- Sep 1, 20268-KCurrent report
- Aug 13, 202610-QQuarterly report · period to Jun 2026
- Aug 12, 20268-KCurrent reportResults of operations
- Aug 10, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Regulation FD disclosure
- Jun 2, 20268-KCurrent reportShareholder vote
- May 14, 202610-QQuarterly report · period to Mar 2026
- May 13, 20268-KCurrent reportResults of operations
- Apr 10, 2026DEF 14AProxy statement
Official filings of Park Dental Partners, Inc. with the US Securities and Exchange Commission.
Balance sheet
- Total assets
- $178 M
- Total liabilities
- $156 M
- Total equity
- $22 M
As of December-2025
Top 25 institutional investors in Park Dental Partners, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Kennedy Capital Management LLC | 230,418 | -6,387 (-2.70%) | 4.16% | $5 M | Nov 13, 2026 |
| 2 | Heartland Advisors Inc | 200,000 | 0 (0.00%) | 3.61% | $4 M | Nov 10, 2026 |
| 3 | Pacific Ridge Capital Partners, LLC | 137,223 | -35,525 (-20.56%) | 2.48% | $3 M | Nov 12, 2026 |
| 4 | Vanguard Capital Management LLC | 93,867 | +27,451 (+41.33%) | 1.70% | $2 M | Nov 13, 2026 |
| 5 | Punch & Associates Investment Management, Inc. | 75,202 | +8,182 (+12.21%) | 1.36% | $2 M | Nov 16, 2026 |
| 6 | Russell Investments Group, Ltd. | 72,876 | -15,288 (-17.34%) | 1.32% | $1 M | Nov 6, 2026 |
| 7 | Royal Bank Of Canada | 44,487 | +23 (+0.05%) | 0.80% | $1 M | Nov 16, 2026 |
| 8 | Citadel Advisors LLC | 40,537 | -12,912 (-24.16%) | 0.73% | $1 M | Nov 16, 2026 |
| 9 | Geode Capital Management, LLC | 33,039 | +12,246 (+58.89%) | 0.60% | $1 M | Nov 6, 2026 |
| 10 | Marshall Wace, LLP | 31,918 | +7,163 (+28.94%) | 0.58% | $1 M | Nov 13, 2026 |
| 11 | Vanguard Fiduciary Trust Co | 25,666 | +13,583 (+112.41%) | 0.46% | $1 M | Nov 13, 2026 |
| 12 | Bleakley Financial Group, LLC | 23,744 | New | 0.43% | $0 M | Nov 13, 2026 |
| 13 | Renaissance Technologies LLC | 22,500 | +3,900 (+20.97%) | 0.41% | $0 M | Nov 12, 2026 |
| 14 | SEI Investments Co | 16,057 | 0 (0.00%) | 0.29% | $0 M | Nov 10, 2026 |
| 15 | Boston Partners | 12,163 | -1,080 (-8.16%) | 0.22% | $0 M | Nov 10, 2026 |
| 16 | BlackRock, Inc. | 11,984 | +6,399 (+114.57%) | 0.22% | $0 M | Nov 13, 2026 |
| 17 | Walleye Capital LLC | 11,784 | New | 0.21% | $0 M | Nov 13, 2026 |
| 18 | Vanguard Global Advisers, LLC | 1,600 | New | 0.03% | $0 M | Nov 13, 2026 |
| 19 | Tower Research Capital LLC (TRC) | 1,463 | +1,248 (+580.47%) | 0.03% | $0 M | Nov 16, 2026 |
| 20 | Farther Finance Advisors, LLC | 1,140 | New | 0.02% | $0 M | Oct 8, 2026 |
| 21 | UBS Group AG | 863 | New | 0.02% | $0 M | Nov 10, 2026 |
| 22 | Jpmorgan Chase & Co | 684 | +36 (+5.56%) | 0.01% | $0 M | Nov 12, 2026 |
| 23 | Morgan Stanley | 500 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 24 | Osaic Holdings, Inc. | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 25 | Smartleaf Asset Management LLC | 97 | +39 (+67.24%) | 0.00% | $0 M | Nov 10, 2026 |
Mutual funds holding Park Dental Partners, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Heartland Value FundHeartland Advisors | 200,000 | $4 M | 3.6% | 0.37% | +5.5% | Jun 30, 2026 |
| 🇺🇸 Adara Smaller Companies FundRBB Fund, Inc. | 52,950 | $1 M | 0.96% | 0.12% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 43,086 | $1 M | 0.78% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 30,767 | $1 M | 0.56% | 0.06% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 19,248 | $0 M | 0.35% | <0.01% | −0.3% | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers Fidelity U.S. Total Stock FundStrategic Advisers LLC | 13,113 | $0 M | 0.24% | <0.01% | +69% | May 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 8,691 | $0 M | 0.16% | <0.01% | new | May 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 7,639 | $0 M | 0.14% | 0.07% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 5,222 | $0 M | 0.09% | <0.01% | +54% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 2,249 | $0 M | 0.04% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 2,124 | $0 M | 0.04% | <0.01% | +87% | May 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 1,228 | $0 M | 0.02% | <0.01% | new | May 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 518 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 363 | $0 M | <0.01% | <0.01% | +85% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 14 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Park Dental Partners, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Alan Siems LawSee Remarks, Director | Gift | -40 | — | — | 181,001 | Form 4 |
| filed | Alan Siems LawSee Remarks, Director | Gift | -40 | — | — | 180,961 | Form 4 |
| filed | Peter G. SwensonCEO and Chairman, Director | Buyamended | +3,169 | $13.00 | $41 K | 238,381 | Form 4/A |
| filed | Philip Irving SmithDirector | Buy | +769 | $13.00 | $10 K | 3,569 | Form 4 |
| filed | Peter G. SwensonCEO and Chairman, Director | Buy | +3,846 | $13.00 | $50 K | 239,058 | Form 4 |
| filed | Christopher James BernanderChief Financial Officer, Director | Buy | +1,923 | $13.00 | $25 K | 55,756 | Form 4 |
| filed | Todd Christopher GerlachDirector | Buy | +7,692 | $13.00 | $100 K | 68,847 | Form 4 |
| filed | Christopher Charles SmithDirector | Buy | +7,692 | $13.00 | — | 10,492 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Park Dental Partners, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
IPO: priced · IPO calendar
Trading halts
- 2025-12-03 16:32 UTC, code LUDP, resumed 16:37 UTC
Fails to deliver
- : 1,565 shares at $19.00
- : 552 shares at $20.50
- : 44 shares at $20.18
- : 98 shares at $20.28
- : 244 shares at $20.59
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Park Dental Partners, Inc. scorecard#
Passes 3 of the 4 checks that could be worked out. Fiscal year 2025; market cap of Oct 15, 2026.
Valuation0 of 1
- –P/E below its peers' medianNo P/E on file.
- ✗Price to book below its peers' median4.8×Price to book 4.8× against Healthcare's median of 3.1×.
- –Price to sales below its peers' medianNo Price to sales on file.
- –Free cash flow yield above 5%No free cash flow yield on file.
- –Earnings yield above the 10-year Treasury yieldNo P/E on file.
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growthnot known
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitabilitynot known
- –Profitable in the newest yearNo net income on file.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health3 of 3
- ✓Short-term assets cover short-term liabilities1.1×Current ratio 1.06 at the end of fiscal 2025.
- ✓Debt below equity0.6×Debt to equity 0.55 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $13 M at the end of fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Healthcare, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Events at Park Dental Partners, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Cybersecurity incident 2 · Acquisition or sale completed 1 · Material agreement 4 · New debt 2 · Unregistered share sale 2 · Shareholder vote 1 · Results announced 4
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Acquisition or sale completedMaterial agreementNew debtUnregistered share sale | 8-K | |
| Cybersecurity incident | 8-K | |
| Cybersecurity incident | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreement | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2026 | $9 M | Private placement after listing | $2 to $10 million | 1 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How Park Dental Partners, Inc. compares in Healthcare
- Market cap$105 M · higher than 27% of 2,013
- Price / book4.8× · lower than 31% of 1,245
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Park Dental Partners, Inc.🇺🇸 | $105 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 15, 2026
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Park Dental Partners, Inc.? Verify and update this profile — free
Show Park Dental Partners, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.